Abstract

The current diagnostic biomarkers of acute myocardial infarction (AMI), troponins, lack specificity and exist as false positives in other non-cardiac diseases. Previous studies revealed that cuproptosis, ferroptosis, and immune infiltration are all involved in the development of AMI. We hypothesize that combining the analysis of cuproptosis, ferroptosis, and immune infiltration in AMI will help identify more precise diagnostic biomarkers. The results showed that a total of 19 cuproptosis- and ferroptosis-related genes (CFRGs) were differentially expressed between the healthy and AMI groups. Functional enrichment analysis showed that the differential CFRGs were mostly enriched in biological processes related to oxidative stress and the inflammatory response. The immune infiltration status analyzed by ssGSEA found elevated levels of macrophages, neutrophils, and CCR in AMI. Then, we screened 6 immune-related CFRGs (CXCL2, DDIT3, DUSP1, CDKN1A, TLR4, STAT3) to construct a nomogram for predicting AMI and validated it in the GSE109048 dataset. Moreover, we also identified 5 pivotal miRNAs and 10 candidate drugs that target the 6 feature genes. Finally, RT-qPCR analysis verified that all 6 feature genes were upregulated in both animals and patients. In conclusion, our study reveals the significance of immune-related CFRGs in AMI and provides new insights for AMI diagnosis and treatment.

Details

Title
Potential diagnostic biomarkers: 6 cuproptosis- and ferroptosis-related genes linking immune infiltration in acute myocardial infarction
Author
Miao, Mengdan 1 ; Cao, Shanhu 2 ; Tian, Yifei 2 ; Liu, Da 2 ; Chen, Lixia 2 ; Chai, Qiaoying 3 ; Wei, Mei 4 ; Sun, Shaoguang 5 ; Wang, Le 4 ; Xin, Shuanli 3 ; Liu, Gang 4 ; Zheng, Mingqi 2   VIAFID ORCID Logo 

 The First Hospital of Hebei Medical University, Department of Cardiology, Shijiazhuang, China (GRID:grid.452458.a); Hebei Key Laboratory of Heart and Metabolism, Shijiazhuang, China (GRID:grid.452458.a); Handan First Hospital, Department of Cardiology, Handan, China (GRID:grid.452458.a) 
 The First Hospital of Hebei Medical University, Department of Cardiology, Shijiazhuang, China (GRID:grid.452458.a); Hebei Key Laboratory of Heart and Metabolism, Shijiazhuang, China (GRID:grid.452458.a) 
 Handan First Hospital, Department of Cardiology, Handan, China (GRID:grid.452458.a) 
 The First Hospital of Hebei Medical University, Department of Cardiology, Shijiazhuang, China (GRID:grid.452458.a) 
 Hebei Medical University, Department of Biochemistry and Molecular Biology, Shijiazhuang, China (GRID:grid.256883.2) (ISNI:0000 0004 1760 8442) 
Pages
159-170
Publication year
2023
Publication date
Aug 2023
Publisher
Nature Publishing Group
ISSN
14664879
e-ISSN
14765470
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2852215849
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.